Tuberous sclerosis

Jan 27, 2020

Tuberous Sclerosis Alliance Lauds Lundbeck And FDA For Sabril Label Expansion For Patients 2 To 10 Years Old

Apr 30, 2019

TSC Global Awareness Day Scheduled for May 15

Nov 29, 2018

Tuberous Sclerosis Alliance Preclinical Consortium Announces New Staff and Company Members

May 15, 2018

Tuberous Sclerosis Alliance Announces New Global Partnerships in India and Thailand

Apr 30, 2018

Tuberous Sclerosis Complex Global Awareness Day Scheduled for May 15

Apr 10, 2018

Novartis drug Afinitor DISPERZ® receives FDA approval to treat TSC-associated partial-onset seizures

Apr 10, 2018

Tuberous Sclerosis Alliance salutes FDA approval of Afinitor® DISPERZ (everolimus) as the first adjunctive treatment approved in US for patients aged 2 years and older with tuberous sclerosis complex (TSC)-associated partial-onset seizures

Jan 04, 2018

Tuberous Sclerosis Alliance Announces New Global Partnership in Hungary

Oct 27, 2017

Tuberous Sclerosis Alliance Submits "Voice of the Patient" Report To FDA